Karin Cederbrant

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

Andreas Kindmark, A Jawaid, Chris Harbron et al. · The Pharmacogenomics Journal · 2007 · 365 citations

Genetic Epidemiology, Immunology, Pathology +17

Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver Injury

Manal Monshi, Lee Faulkner, Andrew Gibson et al. · Hepatology · 2012 · 249 citations · Full text

MELISA—an in vitro tool for the study of metal allergy

Věra Stejskal, Karin Cederbrant, Anders Lindvall et al. · Toxicology in Vitro · 1994 · 105 citations

Environmental Allergy, Allergy, Allergy Medicine +10

In vitro Lymphocyte Proliferation as Compared to Patch Test Using Gold, Palladium and Nickel

Karin Cederbrant, Per Hultman, Jan A. Marcusson et al. · International Archives of Allergy and Immunology · 1997 · 99 citations

Three‐color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood

Stephen D. Dertinger, Kevin Camphausen, James T. MacGregor et al. · Environmental and Molecular Mutagenesis · 2004 · 83 citations